ILONOV
Biotechnology Research • 
Boulevard René Leriche, Strasbourg, France • 1-10 Employees
Company overview
| Headquarters | Boulevard René Leriche, Strasbourg, France |
| Website | |
| NAICS | 541714 |
| Keywords | Diabetes, Research, Health, Expertise, Innovation, Recherche, Muscle, Prévention, Biotechnologie, Traitement, Diabète, Médicament Naturel |
| Founded | 2020 |
| Employees | 1-10 |
| Socials |
Key Contact at ILONOV
Anastasia Grabarz
CEO
ILONOV Email Formats
ILONOV uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@ilonov-diabetes.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@ilonov-diabetes.com | 100% |
About ILONOV
The European Diabetes Study Center has gathered a team of renowned scientific and medical experts, pioneers in their field of expertise, to fund a biotech company, ILONOV, focused on developing a novel class of therapeutics using the therapeutic potential of our muscle-derived biologic. We aim at satisfying unmet medical needs in Type 1 Diabetes therapy by bringing to the market a first-in-class treatment for curing and preventing T1D and using our discovery to open up a new field of therapeutics.
ILONOV revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ILONOV has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
ILONOV has never raised funding before.
United States
United Kingdom
Canada
Australia
SwedenFrequently asked questions
4.8
40,000 users
